| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 | Translate Bio, A Sanofi Company Developing mRNA vaccines and therapeutics In September 2021, Sanofi acquired Translate Bio, a clinical-stage mRNA therapeutics company. This acquisition further accelerates Sanofi’s efforts to develop transformative vaccines and therapies using mRNA technology. It adds a critical pillar to the company’s mRNA Center of Excellence, which aims to unlock the potential of next-generation mRNA vaccines and other strategic areas such as immunology, oncology, and rare diseases. Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We … Type: | 1 | 0 | 1 | 97 |
 |  Evaxion Biotech A/S AI-ImmunologyTM Powered Vaccines Evaxion Biotech A/S is a pioneering TechBio company based upon its AI platform, AI-ImmunologyTM. Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Based upon AI-ImmunologyTM, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. Evaxion is committed to transforming patients’ lives by providing innovative and targeted treatment options. For more information about Evaxion and its groundbreaking AI-ImmunologyTM … Type: | 2 | 0 | 2 | 58 |
 | Imophoron Ltd Our vision is to provide the world with the next-generation of therapeutics for unmet medical needs and future threats. Type: | 2 | 0 | 2 | 13 |
 |  Samphire Neuroscience Building solutions that will define women's health for the 21st century. We started Samphire Neuroscience to build a world where women everywhere have access to scientifically validated wearable technology for their health needs, without having to sacrifice on technology, design or lifestyle. Building on more than thirty years of research and clinical experience, we are developing wearable neurotechnology, the Samphire Headband, that addresses a range of menstrual-cycle related challenges. Want to know more? Reach out to us via founders@samphireneuro.com Neurotechnology, Women's wellness, Menstrual cycle health, Dysmenorrhea, Premenstrual syndrome (PMS), Premenstrual dysphoric disorder (PMDD), Menstrual migraine, Wearables, and Accessories Type: | 2 | 0 | 1 | 10 |
 | Scandinavian Real Heart [Automatic translation follows] With the help of medical technology solutions and innovation we want to save as many heart failure patients as possible. About Scandinavian Real Heart AB – Only around 8,000 heart transplants take place annually worldwide and the availability of donated hearts is very limited. The need is great and patients with heart failure die waiting for a new heart. Scandinavian Real Heart AB is developing a heart pump (TAH) that mimics the body's natural circulation and that can be used as a transitional solution for patients waiting for a heart transplant. Successful studies have been carried out … Type: | 9 | 1 | 8 | 19 |
 | AATec Medical Unlocking the therapeutic potential of AAT AATec Medical GmbH is a biotech company developing a product platform based on recombinant alpha-1 antitrypsin (AAT) for the treatment of inflammatory diseases, virus infections and rare diseases. The first product candidate is a novel AAT formulation for inhalation to treat emerging inflammatory diseases of the lung and respiratory virus infections. Type: | 0 | 0 | 0 | 6 |
 |  XNK Therapeutics INDIVIDUALIZED NK CELL THERAPIES XNK Therapeutics is a clinical-stage biotechnology company developing unique and individualized natural killer (NK) cell-based cancer therapies. The R&D pipeline targets areas of high unmet medical need within both hematological malignancies and solid tumors. The most advanced product candidate, evencaleucel, is being evaluated in a phase II clinical study in combination with the CD38 monoclonal antibody, isatuximab, as consolidation therapy following stem cell transplantation in newly diagnosed multiple myeloma patients. At the core of XNK is a committed and experienced team that includes world-renowned NK cell experts and pioneers in the field. The company has developed … Type: | 2 | 0 | 2 | 11 |
 | CathVision We empower cardiologists to cure cardiac arrhythmias. CathVision is a medical technology company that develops electrophysiology solutions centered around an innovative EP recording system and AI algorithm platform – the ECGenius System with CARDIALYTICS. Committed to empowering physicians to make more informed clinical decisions in the EP lab, CathVision is redefining the necessity of exceptional cardiac electrical signals to diagnose, characterize, and treat the most common heart rhythm disorders. For safety info, visit www.cathvision.com. Medical Devices, Electrophysiology, EKG, ECG, CathLab, EPLab, Arrhythmias, Atrial Fibrillation, AFIB, Heart Failure, Heart Disease, Cardiology, and Cardiac Rhythms Type: | 0 | 0 | 0 | 47 |
 | Molecure Fate can be altered. Molecure is a clinical stage biopharmaceutical company that uses its world leading medicinal chemistry capabilities to discover and develop first in class small molecule drug candidates that directly modulate underexplored protein targets and the function of RNA to treat multiple incurable diseases. Molecure has generated a diverse pipeline of seven distinct programs with the support of leading academic life science institutions globally. Molecure's lead drug candidate is OATD-01, a first-in-class dual chitinase inhibitor for the treatment of fibrotic and inflammatory diseases, including interstitial lung diseases such as sarcoidosis and idiopathic pulmonary fibrosis (IPF). The phase I … Type: | 0 | 0 | 0 | 87 |
 | Sencure Integrated Biosensor Technology Sencure develops chips that helps you measure electrophysiological parameters on the human body in innovative ways. The goal is to have as little influence on a patient’s daily life as possible, combined with a maximum impact on the patient’s life. We bridge the gap between compliance and the best solutions for wearable health. Our expert team understands your needs and even the needs of your customers. Chip Design, Electrophysiology, Low-power Analog Front-ends, Medical Devices, Dry Electrodes, Amplifier Technology, Measurement Technology, Electroencephalography, Electrocardiography, Electromyography, Wearables, and Remote Patient Monitoring Type: | 1 | 0 | 1 | 20 |
 | KDBIO s.a.s. Distributor - cell culture products, hollow fiber cartridges KDBIO is distributing advanced cell culture devices used for : easy expansion of non-adherent cells, mass-production of small uniform spheroids, 3D culture with nanofiber scaffolds and for an easier way to produce monoclonal antibodies. Business Development, Sales, Marketing, and Distribution Type: | 0 | 0 | 0 | 1 |
 | MImAbs SAS Innovative start up developing monoclonal antibodies in cancer and inflammatory diseases MImAbs is an innovative start-up specialized in immunotherapy. Our goal is to develop monoclonal antibodies in cancer and inflammatory diseases for third parties (academics, pharmacuetical companies, biotechnologies, etc.) Anticorps monoclonaux, Immuno-pharmacologie, Génération et bioproduction d'anticorps, and Génération d'immunoconjugués Type: | 3 | 3 | 0 | 34 |
 | Lamina Therapeutics Developing innovative implantable medical devices for orthopaedic applications Lamina Therapeutics is a pioneering biotechnology company, developing innovative medical devices promoting patient's active live. Lamina’s technology consists of a three-dimensional biodegradable wound dressing with nano-reservoirs including active therapeutics in combination with patient’s own stem cells. This unique multifunctional approach offers a variety of potential applications addressing unmet medical needs in the field of orthopaedics, maxillofacial and periodontal lesions. Lamina’s lead product lamina.ONE, offering a hybrid therapeutic action for the repair of cartilage as well as subchondral bone for a full recovery of the articular function, is expected to enter phase I/II … Type: | 0 | 0 | 0 | 4 |
 | Healshape A regenerative medecine company Healshape is a regenerative medecine project. We aim at developing breast regeneration solutions by 3D bioprinting for women who had mastectomy following breast cancer. Biotechnology, Regenerative medecine, Médecine régénérative, Reconstruction mammaire, Cancer du sein, Breast cancer, Breast regeneration, Breast reconstruction, 3D bioprinting, Tissue engineering, Biologie cellulaire, Impression 3D, Funds raising, and Tissue engineered products Type: | 20 | 17 | 14 | 21 |
 | Flash BioSolutions CDMO expert specialized in gene delivery Flash BioSolutions is a World-class CDMO expert in lentiviral vector manufacturing : With our continuum from research to the clinic we support you throughout your projects from R&D to GMP grade. We provide purified and highly concentrated particles from small scale to large scale with the same vector specifications. Flash BioSolutions provides integrative lentiviral vectors and RNA particles. Lentiviral vectors - LentiCare® : Conventional lentiviral vectors, which lead to DNA integrated into the genome, are a leading delivery method for applications which require a stable and long-term gene expression. Ideal for Gene Therapy and … Type: | 20 | 2 | 7 | 49 |
 | DIXI medical Designer and manufacturer of medical devices for functional and stereotactic neurosurgery for the treatment of epilepsy. DIXI medical design and manufactures medical devices for functional and stereotactic neurosurgery for the treatment of epilepsy. Epilepsy, SEEG, and Electrodes Type: | 7 | 2 | 2 | 84 |
 | Cell-Easy Your science-driven CDMO dedicated to Cell Therapy Cell Easy is a rapidly growing Contract Development and Manufacturing Services organization (CDMO) with a dedicated focus on Advanced Cell Therapies. Established in 2017, Cell Easy's commitment extends beyond development and manufacturing; it also places a strong emphasis on regulatory and analytical aspects. Cell Easy offers a comprehensive suite of services, including process development, process scale-up, cGMP manufacturing, and analytical support for immune cells (engineered CAR-T, NK cells, and non-engineered cells) as well as adult stem cells (MSCs, iPSCs, and Exosomes). Our company has achieved significant milestones, such as advancing programs to Phase … Type: | 0 | 0 | 0 | 41 |
 | Mycelium technologies [Automatic translation follows] The incredible potential of mycelium for human nutrition 🍄🥗🌿 MYCTECHS innovation reduces our meat consumption with tasty fungus mycelium based foods. This is achieved through our innovative technology that rehabilitates the benefits of fermentation and promotes a circular economy by giving a second life to agricultural by-products🍄🌿. MYCTECHS innovation reduces our meat consumption with tasty fungus mycelium based foods. This is achieved through our innovative technology that rehabilitates the benefits of fermentation and promotes a circular economy by giving a second life to agro by-products 🍄🌿 alternative proteins, food transition, innovation, Feed, ingredients, agro-industry, nutrition, health, circular … Type: | 14 | 3 | 1 | 5 |
 | ElyssaMed SAS ElyssaMed® will develop the first therapeutic treatment for clinical use comprising several antigenic peptides (epitopes) derived from CTPP and selective for non-small-cell lung cancer, combined with an already marketed vaccine adjuvant. This product once administered to lung cancer patients, will amplify the patients' specific immune responses against tumor cells expressing the antigen CTPP and lead to their destruction. Type: | 4 | 4 | 0 | 2 |
 | BrainPlotting Human PK data from preclinical stages BrainPlotting is a french contract research organization company which offers his knowledge to predict the entrance of drugs into the brain To that end BrainPlotting developped in vitro models based on fresh human tissus and cells. BrainPlotting is incubated at the Brain and Spine Institute (ICM), Paris, France Our core business is the study of pharmacokinetics (PK) in the human brain. The molecules that we study can have CNS targets as well as peripheral targets. To study the brain's PK, BrainPlotting uses the most accurate predictive models and the most recent methods and tools. … Type: | 0 | 0 | 0 | 1 |
 | SpineGuard Securing Implant Placement Making Spine Surgery Safer SpineGuard is a French innovative medical company dedicated to the deployment and adoption of DSG® (Dynamic Surgical Guidance), powerful radiation-free real time sensing technology platform that spans a broad spectrum of skeletal applications from bone drilling instruments to automated placement of bone implants. Uniquely positioned to change the game in orthopedic robotic surgery. Devices, built with the DSG technology, give real-time audio and visual feedback to the surgeons to secure and streamline skeletal implant placement for the benefit of patients, surgeons, operating room staff and healthcare providers. The PediGuard probes are the only … Type: | 1 | 0 | 1 | 29 |
 | 3Biotech 3Biotech provides Innovative solutions continuously to create a new future and impact patient outcomes 3Biotech provides Innovative solutions continuously to challenge, support and accelerate the manufacturing of safe drug candidate. We are your colleagues, partner for the Chemistry, Manufacturing and Control (CMC) to succeed in your project and mission to create a new future and impact patient outcomes. Three Pillars; Safety, Efficacy, Manufacturing are our drivers to secure all steps from the research to the first in human stage with the most innovative project strategy and plan to execution More, we have implemented a human and customer centric organization to … Type: | 2 | 1 | 2 | 4 |
 | Osivax Pioneering A New Class of Universal Vaccines Osivax is a clinical-stage biopharmaceutical company leveraging its novel, self-assembling nanoparticle platform technology, oligoDOM, to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses. The company is establishing proof of concept with its broad-spectrum, “universal” influenza candidate, OVX836, which is currently in Phase 2 clinical trials with over 1200 subjects tested and encouraging efficacy proof of concept data. Osivax’ ambition is to develop a pan-respiratory virus vaccine to prevent all strains of influenza and all variants of sarbecovirus in one single shot. The company … Tags: FrenchTech2030 Type: | 22 | 11 | 14 | 51 |
 | ADEXSOL Adexsol is a consulting and training company based in Paris that provides healthcare companies and institutions with knowledge of the goals, organisation and functioning of the French healthcare system. Adexsol can help you with: - Better understanding and analysing needs of the hospital and healthcare world in order to build an offer meeting key players’ needs. - Setting up training for industry sales forces and managers on topics related to organisation and functioning of the hospital. - Carrying out market research, polls and opinion trackers. - Organising events nationally or regionally: conferences, workshops, seminars, and scientific boards. - Developing your … Type: | 4 | 0 | 2 | 2 |
 | ELSALYS BIOTECH Innovative medicines to address haemato-oncology related life-threatening and rare diseases ElsaLys Biotech is a specialty pharmaceutical company, part of the Mediolanum Farmaceutici Spa group, focused on innovative medicines to address haemato-oncology related life-threatening and rare diseases. Following strategic acquisitions and targeted developments, ElsaLys is establishing an immunotherapeutic portfolio focused on niche specialty pharmaceuticals to answer unmet medical needs. Our commitment is to offer essential drugs meeting Public Health needs. Founded in 2013, ElsaLys Biotech is located in the heart of the European cluster Lyon Biopole, in Lyon, France. Anticorps thérapeutiques, Anticorps monoclonaux, Therapeutic antibodies, Monoclonal antibodies, ophtalmologie, immune microenvironment, vascular … Type: | 7 | 3 | 1 | 1 |
 | SLS France [Automatic translation follows] SLS France is a company being created in the Rennes area. This structure will allow the manufacture of chrome-cobalt dental prostheses by micro-fusion. Based on a multidisciplinary team competent in this technology, our desire is to offer a quality product that perfectly meets the needs of our future customers. Type: | 3 | 0 | 0 | 15 |
 | Unooc [Automatic translation follows] The ambition of the Unooc.fr site is to support pharmacists on the Internet and to guarantee Internet users a purchase in a French pharmacy approved by the government. + For pharmacists: increased visibility, geolocation, highlighting of their advice and offers. + For French people: buy safely and at the best price. In one click, Unooc allows you to find: - Medicines, - Homeopathy, - Beauty products, - Baby products, etc. More than 50,000 references among around fifty partner French pharmacies. http://www.Unooc.fr/ Health, Internet, E-Commerce, and Search engine Type: | 1 | 1 | 0 | 1 |
 | Happineo [Automatic translation follows] A psychologist who understands you, anywhere, anytime Happineo offers consultations with qualified psychologists from your home by phone and messages. Confidential and simple, our service allows you to start quality therapeutic monitoring very quickly. Health, Well-being, Psychology, occupational health, and psychosocial risks Type: | 0 | 0 | 0 | 1 |
 | eVeDrug [Automatic translation follows] eVeDrug calls upon various stakeholders all linked to the field of Pharmacovigilance: professionals from the pharmaceutical industry and scientists who have pooled their know-how, and who draw on their experience acquired both from industrial circles (laboratories and manufacturers) and institutional circles (health authorities from different countries). Above all, eVeDrug wishes to restore trust between patients and their health system by placing the main person concerned (the patient himself) at the center of the health system responsible for protecting him. Thus, eVeDrug distributes the free My eReport application which allows any person (patient, relative, health professional, etc.) who … Type: | 12 | 2 | 5 | 7 |
 | Healx AI-powered and patient-inspired. We accelerate the discovery and development of rare disease treatments. Healx is a mission-driven technology company pioneering the next generation of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are more than 10,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AI technology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to … Type: | 1 | 0 | 1 | 72 |
 | LenioBio Rapid eukaryotic, cell-free protein expression that scales for research, development and production. At LenioBio, we develop efficient, robust and sustainable technologies to disrupt the way medicines and food are produced for those in need, wherever they are. Unconstrained by the limitations of cells, we combine our proprietary protein technology with machine learning to significantly accelerate innovation cycles in life science industry. Protein Expression, Protein Production, Synthetic Biology, Biotechnology, Membrane proteins, Antibodies, Functional Proteins, Sustainable Foods, Vaccines, Therapeutic Proteins, Structural Biology, Cell-free protein production, Cell-free protein expression, and Plant-based protein Type: | 7 | 1 | 6 | 54 |
 | 64x Bio An evolution in cell line engineering. High throughput engineering of cell lines to enhance the design and manufacture of next-generation therapeutics. Gene therapy, Synthetic Biology, Genome Engineering, and Functional Genomics Type: | 1 | 1 | 0 | 20 |
 | Epiminder Epiminder is a medical device company developing the next generation brain monitoring technology. The company’s first product, the MinderTM system, is an implantable EEG monitoring system designed to detect epileptic seizures. Through long term and continuous EEG measurements, the system will provide unparalleled insights into brain activity, significantly improving the diagnosis and management of epilepsy and helping people with epilepsy take back control of their lives. Epilepsy is complex neurological condition which affects over 80 million people worldwide, 30% of whom don’t respond to medication. The MinderTM system consists of a small implant placed just under the scalp, a multi-channel … Type: | 0 | 0 | 0 | 25 |
 | Neogene Therapeutics Pushing the frontier by pioneering next-generation engineered T cell receptor therapies for solid cancers Neogene Therapeutics is a global, clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation engineered T cell receptor (TCR) therapies targeting a broad spectrum of solid cancers. With offices in Santa Monica, CA and Amsterdam, the Netherlands, Neogene is aiming to change the paradigm of treatment for solid cancers. Neogene is a member of the AstraZeneca Group. Type: | 1 | 0 | 1 | 187 |
 | ITM Isotope Technologies Munich SE Dedicated to giving cancer patients better answers than "maybe". PASSION FOR PRECISION. ITM Isotope Technologies Munich SE is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer treatment. Since its foundation in 2004, ITM and its subsidiaries have established GMP manufacturing and a robust global supply network of a novel, first-in-class medical radioisotopes and generator platform for a new generation of targeted cancer diagnostics and therapies. Furthermore, ITM is developing a proprietary portfolio and growing pipeline of targeted treatments in … Type: | 1 | 0 | 1 | 426 |
 | ADDvise Group AB (publ) Leading supplier of equipment to healthcare and research facilities ADDvise is a leading supplier of equipment to healthcare and research facilities. ADDvise Group AB (publ) is an expanding group that offers total solutions in products and services to healthcare and research facilities through its subsidiaries. We develop and nurtures long-term relationships by offering leading edge competence in our two business units Lab and Healthcare. Our subsidiaries are divided equal into the business fields. Lab creates modern research facilities by providing laboratory furnishings, safety ventilation, climate rooms, clean rooms and laboratory apparatus to e.g. the pharmaceuticals industry and life science research. … Type: | 0 | 0 | 0 | 32 |
 | ALPX Automated protein crystallography for faster new structures and expert small molecule screening. All our services include access to fully automated, remote-controlled protein-to-structure pipelines based on the innovative technologies CrystalDirectTM and CRIMS developed at EMBL. Type: | 2 | 2 | 0 | 16 |
 | RonomA [Automatic translation follows] Providing patients with neurodegenerative diseases with a new, innovative therapeutic approach Type: | 4 | 1 | 3 | 3 |
 | Toxi Plan We anticipate safety for you and the environment Toxi Plan is a regulatory (eco)toxicology services company operating in several sectors of activity, such as raw materials, finished cosmetic products, medical devices, pharmaceuticals, food supplements, foodstuffs, detergents, chemicals, textiles and packaging. Toxi Plan supports you in the assessment of (eco)toxicological risks to meet regulatory and safety requirements for the placing on the market of finished products in Europe and internationally. Our services by sector of activity: RAW MATERIALS: - (Eco)toxicological assessment of ingredients/substances, - Drafting of safety data sheets (SDS), - Preparation of the REACh registration dossier. COSMETICS: - Toxicological and … Type: | 2 | 2 | 0 | 9 |
 | Biopredic International Biopredic International is committed to support Life Science Research by developing and distributing biological tools. We assist both academia and industries in drug development, drug discovery, cosmetic and chemical fields. Biopredic International delivers assays, tissues, cells and reagents including: > High quality hepatocytes (human and animal, fresh or cryopreserved) and other liver-derived products (microsomes, S9 fractions and cytosols) > Skin products (fresh or frozen), including human skin discs and skin sheets (full thickness, dermatomed, stratum corneum), skin cells (keratinocytes, fibroblasts), subcellular fractions... > Blood products, including whole blood, sera, plasma, PBMCs, lymphocytes, monocytes, dendritic cells, CD34... > And other products … Type: | 3 | 2 | 1 | 25 |
 | OrganOx Our mission is to save lives by making every donated organ count "Living Organs For Life" Transforming transplantation with the OrganOx metra®. A transportable, automated ex vivo liver perfusion device. The core technology employed by the OrganOx metra® has been in development for over 15 years. During this time both of the founders (Professor Peter Friend and Professor Constantin Coussios) have driven the development of organ preservation and maintenance, formerly at the University of Cambridge and latterly at the University of Oxford. OrganOx Limited was founded in April 2008 as a spin-out from the University of Oxford. Conventional cold preservation … Type: | 1 | 1 | 0 | 132 |
 | Tenpoint Therapeutics Ltd Vision-restoring engineered cell-based therapeutics & in vivo reprogramming. Tenpoint Therapeutics is a vision-restoring engineered cell-based therapeutics company. We are embracing a new opportunity to fundamentally reshape the future for people with ocular diseases. We have an ambitious goal with global impact. Type: | 2 | 2 | 0 | 27 |
 | HiProMine S.A. Sustainable and eco-friendly solutions to provide nutritious products based on novel protein source. HiProMine S.A. specializes in insect based raw materials production for livestock and companion animals. We offer high quality insect meal (dry form), insect pulp (fresh meat), and insect dried larvae, produced from Black Soldier Fly - Hermetia illucens. Our meals are dried and processed in low temperature which improves digestibility and nutritive values for animals. Our production is compliant with veterinary control standards, biosecurity, prevention of diseases, and GMP+/HACCP rules. All substrates used in insect rearing are vegetable based and GMO free. Looking to alternative and sustainable … Type: | 0 | 0 | 0 | 54 |
 | VISUfarma - the eye health company Creating value in eye health for our patients worldwide VISUfarma is a pan-European ophthalmic pharmaceutical company with a clear mission: to bring quality products and global therapeutic innovation to European eye health. We are an ambitious and fast growing ophthalmology company, commercializing a broad portfolio of pharmaceutical products and medical devices across Europe. (www.VISUfarma.com). The company was formed in 2016 and is the result of the successful combination of the Italian company Visufarma SpA and the commercial activities of the international Nicox SA, headquartered in France. The combination created VISUfarma. We offer a complete portfolio of products in the areas … Type: | 0 | 0 | 0 | 99 |
 | LUMICKS Empowering scientists with tools that reveal crucial insights not available before, at the molecular and cellular level. LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. Our instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells. Built upon innovative and Nobel Prize-winning technologies, such as optical tweezers (Nobel Prize for Physics 2018), and STED super-resolution (Nobel Prize for Chemistry 2014), our tools enable the understanding of life to the smallest detail. Our goal is to advance science and improve human … Type: | 4 | 2 | 2 | 175 |
 | MedApp Nederland [Automatic translation follows] MedApp. The smart pharmacy. For a healthcare professional, the importance of adequate medication adherence is no secret. Unfortunately, around forty percent of patients fail to consistently administer medication. There are more than three hundred underlying causes, many of which can be classified as procrastination, forgetfulness or insufficient stock. MedApp gives medication users control over medication by offering a solution that actually works. Moreover, MedApp goes beyond the medication user by linking to the professional healthcare world. By registering medication intake, a healthcare provider can easily gain insight into the intake behavior within the population and a pharmacist … Type: | 0 | 0 | 0 | 64 |
 | Citryll Translating NET biology into novel therapies for inflammatory diseases Citryll has translated a deep understanding of the neutrophil extracellular trap (NET) pathway to therapeutically address its central role in a broad range of inflammatory diseases. With a unique dual mode of action, the company’s lead antibody, CIT-013, has reached the clinic by demonstrating a precise and powerful ability to control NETs and NETosis. Citryll is initially developing CIT-013 as a novel drug for rheumatoid arthritis and hidradenitis suppurativa, which may serve as enabling indications for a wide spectrum of inflammatory diseases. The initial clinical trials with CIT-013 are expected to … Type: | 0 | 0 | 0 | 25 |
 | Meatable We're pioneering a way to produce real, tasty meat without harming animals or the planet. It isn’t like meat, it is meat Meatable makes 100% real, delicious, guilt-free meat. With one cell, we are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time we increase food security, without compromising the culinary experience of eating tasty, real meat. cultivated meat Type: | 5 | 3 | 2 | 137 |
 | Magnosco GmbH Magnosco GmbH, founded in 2014, is a MedTec Company based in the technology park Berlin-Adlershof. We offer a non-invasive method supporting (early) detection of malignant melanoma based on laser technology. CEO Inga Bergen and COO Thomas Diepold lead the team of scientist and technical experts. Magnosco cooperates with Charité Berlin, University Hospital of Tübingen and the University Hospital of Heidelberg, hospital operator Vivantes and LTB Lasertechnik Berlin regarding the development and certification as a medical device. More and more people know that if skin lesions are changing a doctor’s expertise is very important to detect skin cancer early on. Especially … Type: | 0 | 0 | 0 | 15 |
 | PreOmics SETTING THE STANDARD FOR PROTEIN ANALYSIS PreOmics empowers its clients in life sciences to establish biological knowledge through efficient, reliable solutions and workflows that set the standard for protein analysis. Our team spirit, energy, and commitment empower us to be both creative and quality-focused – A trusted partner with deeply rooted scientific experience.We envisage a future with revolutionary proteomic discovery processes open for everyone. Tools that reveal hidden causes of diseases, ensure sustainable nutrition, and provide diagnoses that enhance lives and society. PreOmics GmbH Am Klopferspitz 19 82152 Planegg/Martinsried Germany Contacts: Telephone: +49-89-2314163-0 Telefax: +49-89-2314163-99 Email: info@preomics.com Privacy Policy: https://www.preomics.com/legal/data-privacy-policy … Type: | 1 | 0 | 1 | 62 |
 | NUMAFERM Biomade Peptides We believe that in the near future peptides have found their way into new markets and are a well-known feed stock for better products in life sciences and beyond. NUMAFERM supports you in these developments – from discovery to commercial production. Type: | 2 | 1 | 2 | 17 |
 | Immunic Therapeutics Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases Immunic (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. Privacy Policy: https://imux.com/privacy-policy/ Type: | 3 | 0 | 3 | 82 |
 | Noscendo GmbH Using #NGS of cell free nucleic acids to identify over a thousand microbes we change the way #pathogens are identified Noscendo GmbH, a Duisburg (Germany) based molecular diagnostics company, changes the way infection causative microbes are identified. Introducing a paradigm shift using proprietary algorithms and software harnessing next generation sequencing of cell free nucleic acids isolated from patient samples Noscendo brings the concept of liquid biopsy into the field of infectious diseases. Noscendo’ s software solution is capable of differentiating infection from non-infectious signals and thereby aiding intensive care clinicians in their daily task to find the right decisions, enabling … Type: | 1 | 1 | 0 | 48 |
 | Belyntic GmbH The Precision Vaccines Company Belyntic creates novel vaccines for viral diseases with unmet medical need. We have developed and validated a new platform technology, that generates self-adjuvant synthetic long peptides for a safe and durable induction of cellular immunity. Drug development, Cellular immunity, and Platform technology Type: | 1 | 0 | 0 | 2 |
 | IRUBIS Innovative Process Analytical Spectroscopy for Upstream and Downstream Processing IRUBIS | Innovative Process Analytical Spectroscopy for Biomanufacturing. IRUBIS is a company that specializes in mid-infrared (MIR) spectroscopy for bioprocessing. We have designed an instrument, Monipa, specifically for bioprocess monitoring and control. Monipa is based on MIR spectroscopy, making it possible to monitor multiple bioprocesses real-time and continuously. Our instrument's applications are foreseen in both upstream and downstream bioprocessing. These include multiple metabolite monitoring and control in upstream processing. In addition, contaminant detection or monitoring of target proteins and excipients can be aided in downstream processing. Read more about our products … Type: | 5 | 0 | 3 | 18 |
 | Angiolutions We turn science into medicine. Angiolutions – breaking new ground in abdominal aortic aneurysm (AAA) treatment. Abdominal aortic aneurysms are threatening the lives of millions of patients around the world with no way to intercept early disease progression. Angiolutions will change that. Angiolutions is the first company to develop a therapeutic device preventing disease progression in small abdominal aortic aneurysms. Type: | 1 | 0 | 1 | 9 |
 | TetraKit Technologies Next Generation Theranostics TetraKit Technologies (2021) is a spin-off company originating from the University of Copenhagen (KU). Our mission is to revolutionize theranostic agent development through our unique chemistry - The TetraKit Platform. It allows for one-fits-all radiolabeling of most targeting vectors with optimal diagnostic and therapeutic radionuclides. We develop both, our core platform technology, as well as proprietary novel theranostic radiopharmaceuticals based on our platform. This technology is based on the latest advancements in click chemistry and radiolabeling techniques coming from our laboratories. We are interested in partnerships to combine our radiolabeling platform with emerging targeting vectors. Radiopharmaceuticals, Nuclear … Type: | 1 | 1 | 0 | 97 |
 | Rebiotix Inc (a Ferring Company) A Ferring Company working to harness the power of the human microbiome to address unmet medical needs. Rebiotix Inc, part of the Ferring Pharmaceuticals Group, is a clinical-stage biotechnology company revolutionizing the treatment of challenging gastrointestinal diseases by harnessing the power of the human microbiome. Our highly skilled and dynamic team is based out of Roseville, Minnesota. Please feel free to contact us through our website at www.rebiotix.com. Biotechnology, Microbiome, Drug Development, Medicine, Clinical Trials, Regulatory Innovation, Patient Support, Internal Medicine, Manufacturing, Infectious Disease, Gastroenterology, Emerging Diseases, and Novel Technology Type: | 0 | 0 | 0 | 90 |
 | Karyopharm Therapeutics Inc. Discovers, develops and commercializes novel, life-changing cancer therapies in disease areas with high unmet need. Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. As an organization, Karyopharm is on a mission to improve lives and defeat cancer. In its role as leaders in XPO1 inhibition, Karyopharm delivers on its mission by creating a focused pipeline that targets multiple high unmet need cancer indications, including multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma (DLBCL). oncology, pharmaceutical, biotech, … Type: | 4 | 0 | 1 | 399 |
 | Nanna Therapeutics Totally Integrated Medicines Engine (TIME) to Cure Diseases Type: | 0 | 0 | 0 | N/A |
 | Oncoheroes Biosciences A Biotech Company 100% Focused On Advancing New Therapies For Childhood Cancer A life science company exclusively focused on finding cures for childhood cancer by identifying and developing the most promising projects to create new treatments and drugs. drug development, clinical development, and childhood cancer Type: | 4 | 0 | 2 | 11 |
 | Vicore Pharma AB Vicore is an innovative clinical-stage pharmaceutical company unlocking the potential of a new class of drugs with disease-modifying potential. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Buloxibutid (C21) is a first-in-class orally available small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2a development for IPF. AlmeeTM (an investigational medical device in clinical development) is a digital therapeutic based on cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis. Almee has received Breakthrough Device Designation from the FDA, reflecting its potential to have transformative impact. … Type: | 0 | 0 | 0 | 39 |
 | PhoreMost Ltd Drugging the Undruggable® PhoreMost is a new-model drug discovery company based in Cambridge, UK. We are dedicated to ‘Drugging the Undruggable®’ disease targets using our next-generation technology, SITESEEKER®. Using PROTEINi® libraries, this unique drug target identification platform can discern the best new targets for future therapy and crucially, how to drug them, which has the potential to significantly increase the diversity and affordability of novel therapeutics for cancer and other unmet diseases. PhoreMost is building a pipeline of novel drug discovery programmes aimed at addressing a range of diseases, with a mission to accelerate, diversify and rationalise drug discovery. Using … Type: | 4 | 0 | 1 | 56 |
 | DACER Rehabilitación Funcional daño cerebral [Automatic translation follows] Where there is a dream...there is a way DACER Functional Rehabilitation is a non-profit organization specializing in the rehabilitation of patients with brain damage, whether congenital or acquired. We know and experience Brain Damage as something of our own. More than 80% of the shares are from members with affected families. Its founding members are neurological physiotherapists, occupational therapists, speech therapists, neuropsychologists and neuro-rehabilitation physicians. It has the technical and business support of its president and its engineering and new technology companies - Quálitas and CBM Management-. Our reason for being encompasses all activities related to the … Type: | 0 | 0 | 0 | 41 |
 | Trutino Biosciences ON DEMAND CYTOKINE Company Trutino means ‘Balance’ in Latin, and this represents our strategy, namely an Rx/Dx approach for Precision Oncology Drug & Clinical Development. The company logo symbolizes well balanced wings. As it takes both wings to fly, we believe a balanced Rx/Dx drug development will ultimately deliver on the promise of Precision Oncology. Our effort focuses on ‘targeted destruction of cancer cells’ and simultaneous ‘differential activation of tumor-specific immune cells’ to maximize treatment response. ON DEMAND CYTOKINE, CYTOKINE DRUG, IMMUNO-ONCOLOGY, and TARGETED ONCOLOGY Type: | 0 | 0 | 0 | 16 |
 | Enterprise Therapeutics Dedicated to the development of novel therapies to improve the lives of patients with respiratory disease Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life. The leadership team has significant expertise in drug discovery, drug development, respiratory biology and ion channel pharmacology. … Type: | 1 | 1 | 1 | 12 |
 | Biognosys Transforming life sciences with cutting-edge proteomics technology and solutions The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented. Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision making. Our Solutions We offer a versatile portfolio of proprietary proteomics services, software, and kits. We make these widely available for pharmaceutical and biotechnology researchers and proteomics experts. Our solutions provide a multi-dimensional view of protein expression, function, and structure in all major sample types – cells, tissues, or body fluids – across human … Type: | 4 | 0 | 4 | 90 |
 | T3 Pharmaceuticals AG Developing the next generation bacterial cancer therapy Developing the next generation bacterial cancer therapy The vision of T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments. Despite significant advances of classical therapies, there remains a high need for novel and innovative medicines to treat cancer. T3 Pharmaceuticals is dedicated to fill this gap by developing highly specific and efficient treatments using live bacteria. T3 Pharmaceuticals was founded in May 2015 by Simon Ittig, Christoph Kasper, Marlise Amstutz and Helmut Kessmann as a spin-off of the University of Basel. The team has developed an efficient protein … Type: | 1 | 1 | 0 | 24 |
 | BiomX Inc Customized phage therapies to eradicate harmful bacteria in chronic diseases BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. Microbiome, Biotechnology, Drug Discovery, and Phage Therapies Type: | 1 | 0 | 1 | 70 |
 | Cognito Therapeutics, Inc. Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases. Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer’s disease. Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimer’s disease and expects to start pivotal studies in 2022. The company’s technology was based on pioneering optogenetics research by scientific co-founders Professors Li-Huei Tsai and Ed Boyden at MIT. Type: | 7 | 0 | 3 | 52 |
 | Kymera Therapeutics Inventing a new class of medicines using Targeted Protein Degradation Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Kymera is also progressing degrader oncology programs that target undrugged … Type: | 3 | 0 | 2 | 206 |
 | SOLNATIDE project H2020 project exploring safety, tolerability and clinical efficacy of solnatide IMP in COVID-19 patients. The SOLNATIDE project will clinically test the safety, tolerability and clinical efficacy of solnatide IMP in patients with severe COVID-19 requiring mechanical ventilation. APEPTICO’s lead-compound solnatide IMP has been designed for the therapeutic treatment of patients with Acute Respiratory Distress Syndrome (ARDS) and various forms of Pulmonary Oedema (PPO). Orally inhaled solnatide has delivered clinical proof-of-concept in one Phase I and two Phase IIa clinical studies (EUDRACT No. 2011-000223-33, 2012-001863-64 and 2013-000716-21). Currently, solnatide is subject to a Phase IIB trial (EUDRACT No. 2017-003855-47) being approved … Type: | 0 | 0 | 0 | N/A |
 | Proxygen The Art of Glue Hunting A curious team of explorers, deeply rooted in science, and constantly on the lookout for a very particular novel drug modality. This is us – Proxygen. We hunt for glue degraders. They are the key to unlocking new treatments for patients. They revolutionize how we see and cure diseases. Type: | 1 | 0 | 0 | 37 |
 | OXGENE A WuXi Advanced Therapies company, based in Oxford, UK. OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and service solutions they need to come first in the race to deliver ground-breaking therapeutics. OXGENETM is headquartered in Oxford, UK. For additional information, please visit our website. PRODUCTS: Largest collection of standardised plasmids on the market and SERVICES: DNA Services, Protein Production Services, Virus Services, Cell Line Development Services. Type: | 3 | 0 | 0 | 58 |
 | ASCIL Biopharm We make injectable products better Ascil Biopharm is a Drug Delivery System company specialized in Long Acting Injectables (LAI) and devices. Our Research and development is focused in Controlled Release Formulations (CRF) and precision medical devices to enhance efficiency, safety, and patient convenience. Controlled Release Formulations, Long Acting Injectables, Drug Delivery Systems, and Parenteral Type: | 0 | 0 | 0 | 26 |
 | Enara Bio Advancing cancer immunotherapy by targeting the unconventional Enara Bio is shining a light on Dark Antigen® and T-cell biology to develop cancer immunotherapies designed to improve treatment outcomes for broad populations of cancer patients. Our pioneering EDAPT® platform enables us to discover novel cancer-specific antigens from previously uncharted genomic ‘dark matter’. The result is a growing database of Dark Antigens that can address the unmet need for cancer-specific targets that are homogenously expressed and highly prevalent in solid tumors. We are advancing multiple approaches to exploit these Dark Antigen targets, with an internal focus on TCR-directed immunotherapies, and additional therapeutic … Type: | 6 | 1 | 3 | 61 |
 | Axonis Therapeutics Axonis Therapeutics is advancing breakthrough discoveries to develop first-in-class therapies for neurological disorders Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2, the critical mediator of inhibition within the brain, by translating breakthrough discoveries spun out from Boston Children’s Hospital, Harvard and Laval University. We are an exceptional team of drug hunters and target biology experts who have built a proprietary KCC2 discovery engine based on several years of world-leading know-how, to become the leaders in this potential blockbuster drug space. A venBio portfolio company, Axonis has raised $34+M in dilutive Seed funding, and … Type: | 6 | 0 | 3 | 19 |
 | Gubra Science of certainty Founded in 2008, we are a biotech company with two primary areas of business: Preclinical contract research organization (CRO) services and proprietary early target and drug discovery programs. Our focus is the metabolic space (e.g. obesity, diabetes, NASH and gastrointestinal diseases), where we specialize in peptide chemistry, in vivo pharmacology, ex vivo assays, molecular pharmacology, histology, imaging, stereology, NGS (next generation sequencing) and bioinformatics. Gubra is an abbreviation for GUt and BRAin, the original key focus areas of our research and expertise. We work with some of the most interesting and loyal partners and customers from across … Type: | 2 | 0 | 2 | 257 |
 | G1 Therapeutics, Inc. Our mission is to discover, develop and deliver next generation cancer therapies. G1 Therapeutics, Inc. is a commercial-stage oncology company focused on the development and commercialization of next generation anti-cancer therapies. Led by a team with a deep understanding of the biology of cancer and extensive development and commercialization expertise, G1 is advancing its mission to improve the lives of those affected by cancer, including by commercializing the Company’s first commercial product, COSELA® (trilaciclib). G1 is also executing a development program, with a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including breast, lung, and … Type: | 1 | 0 | 0 | 88 |
 | Biome Diagnostics Advancing cancer care through microbiome profiling 🦠 Discover your microbiome: www.mybioma.com Biome Diagnostics GmbH (BiomeDx®) is an Austrian based MedTech company committed to advance precision medicine by pioneering microbiome-based technologies that transform cancer care. The company is strategically positioned at the intersection of state-of-the-art DNA sequencing and advanced machine learning algorithms to develop first in class technologies for routine clinical practice. Additionally to the lifestyle product myBioma (www.mybioma.com) for end-customers, the company focuses on the development of medically certified products in the area of gut microbiome and cancer. As safety and health of patients are top priorities, the company has … Type: | 4 | 0 | 3 | 17 |
 | Delta4ai Delta4 is a Vienna-based biotech startup driving the forefront of digital drug discovery and development. Delta4 is driving the forefront of digital drug discovery and development. We leverage a proprietary computational analytics platform "Hyper-C", combining straightforward biomedical testing and clinical validation of candidate drugs. Our unique approach integrates iterative big data/in silico and experimental screens, offering the most efficient matching of clinical indications and compound/drug effects. drug repositioning, drug discovery, compounds, orphan diseases, indication expansion, AI, and omics Type: | 4 | 0 | 0 | 11 |
 | a:head bio AG we aim to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids a:head’s drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini brains from human stem cells in vitro. They capture the essential aspects of human embryonic brain development including brain patterning, formation of brain ventricles, differentiation into the various neuronal and supportive cell types and their correct three-dimensional arrangement. The technology has been pioneered by the company’s co-founders Madeline Lancaster and Juergen Knoblich and is exclusively licensed to a:head by the Institute of … Type: | 2 | 0 | 1 | 18 |
 | Nanoform Global experts in nanotechnology and drug particle engineering Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services. Nanoform’s capabilities include GMP manufacturing, and its services span the small to large molecule development space with a focus on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications. Type: | 10 | 0 | 4 | 162 |
 | Enanta Pharmaceuticals Our vision is to transform the lives of patients with curative therapies. Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for virology and immunology indications. Enanta’s research and development programs are currently focused on respiratory syncytial virus (RSV) and chronic spontaneous urticaria (CSU) and the company has previously advanced clinical-stage compounds for SARS-CoV-2 (COVID-19) and chronic hepatitis B virus (HBV) infection. Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing chronic hepatitis c virus (HCV) … Type: | 2 | 0 | 2 | 160 |
 | Terns Pharmaceuticals Taking the Journey Towards Comprehensive Treatment of Serious Disease Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist and preclinical GIPR modulator programs. For more information, please visit: www.ternspharma.com. Disclaimer: Reposts and posts of contents are for informational purposes only and do not constitute endorsements or promotions of any third-party products, services or organizations (including any statements, views or conducts by such organizations) unless explicitly stated … Type: | 0 | 0 | 0 | 63 |
 | Sixfold Bioscience RNA delivery, evolved. RNA delivery, evolved. Drug delivery, RNA, and RNA delivery Type: | 4 | 0 | 3 | 33 |
 | Karuna Therapeutics Pushing the boundaries of neuroscience to transform the treatment of mental illness. Karuna Therapeutics, Inc. is now part of Bristol Myers Squibb. Learn about how we are continuing to transform the lives of patients with neurological and neuropsychiatric diseases @Bristol Myers Squibb or www.bms.com. Type: | 4 | 1 | 4 | 133 |
 | InterAx Biotech Advanced integration of biological systems, math models and artificial intelligence The company, a spin-out of ETH Zurich and the Paul Scherrer Institute, Switzerland, uses high throughput biochemical screening of compounds integrated into an artificial intelligence and cell pathways mathematical modeling process. This platform unlocks previously intractable targets, shortens timelines for drug discovery from years to months and reduces risks. The company focuses on the generation and optimization of drugs which trigger a specific and well characterized effect on signaling pathways, thus leading to higher therapeutic efficacy and reduced risk of toxicity. The company is specialized in GPCR drug discovery and … Type: | 4 | 0 | 3 | 17 |
 | DeNovix Inc. We design, manufacture and sell award-winning lab equipment for today's life scientists. DeNovix Inc., founded in 2012, is a Wilmington, DE, USA based instrumentation company that develops, manufactures and sells laboratory equipment to meet the demands of today’s evolving life science research. DeNovix focuses on providing innovative products and outstanding customer support. The company is equipped with the financial, commercial and technical resources to deliver breakthrough products for research success. DeNovix products include the DS-11 Series Spectrophotometer / Fluorometer, the CellDrop Automated Cell Counter, the QFX Fluorometer and DeNovix assays. Our instruments are stand-alone (no PC needed) and built on … Type: | 1 | 0 | 1 | 27 |
 | PHC Corporation of North America Life Science Innovator Since 1966 PHC Corporation of North America (PHCNA) is headquartered in Wood Dale, IL and manufactures and markets PHCbi brand laboratory equipment. PHCNA is a subsidiary of PHC Holdings Corporation of Tokyo, Japan, a global diversified life sciences, diagnostics, and medical device company. For more than 50 years, PHCNA has met the needs of pharmaceutical, biotechnology, hospital/clinical, and industrial customers, offering a unique perspective on scientific research. We play a critical role in global product development across a range of research areas and have a deeply entrenched reputation as a manufacturer of highly-reliable quality and innovative laboratory … Type: | 3 | 0 | 0 | 203 |
 | invIOs INNOVATIVE IMMUNO-ONCOLOGY Developing tomorrow's cancer therapies. Today. invIOs is a private biotech company focusing on discovery and development of novel cancer therapeutics that empower and educate the immune system to fight cancer. We leverage our deep expertise in immune-system activation to advance a focused pipeline of individualized and targeted approaches against solid tumors. Our focus is on earlier-stage development, with a sweet spot in bringing assets through discovery and pre-clinical development and into clinical trials. We launched in 2022 as a spin-out bundling the innovative oncology assets of APEIRON Biologics. Our highly motivated team of 35 people has deep expertise across the … Type: | 1 | 0 | 0 | 24 |
 | Eveliqure Biotechnologies Eveliqure Biotechnologies is developing novel vaccines for the prevention of diarrhoeal diseases. Eveliqure Biotechnologies is an innovative biotech company developing novel vaccines for the prevention of diarrhoeal diseases both for travellers and people living in endemic regions of low- and middle-income countries. Eveliqure is a game-changer amongst vaccine companies, championing novel technologies to make the world safe from diarrhoea. Eveliqure is passionate about improving the quality of life for both the poor and the privileged by providing innovative medical solutions that fight diarrhoeal diseases. Type: | 1 | 0 | 1 | 6 |
 | QUANTRO Therapeutics GmbH Discovery and development of novel therapeutics targeting transcription factors in cancer and other diseases QUANTRO Therapeutics (“QUANTRO”) is a research-based entity that strives to discover and develop novel therapeutics interfering with disease-causing transcriptional programs in cancer and other diseases. QUANTRO will assemble a highly innovative drug-discovery pipeline that employs time-resolved RNA sequencing and comparative transcriptomics to identify and develop drug candidates interfering with transcriptional regulators. The first focus will be on cancer-associated transcription factors, which so far have been unamenable to pharmacologic intervention. QUANTRO was founded as a spin-off of the Institute of Molecular Biotechnology (“IMBA”) and the Research Institute … Type: | 1 | 0 | 1 | 14 |
 | Surrozen Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway. Surrozen was founded by five leading-edge scientists: K. Christopher Garcia, Ph.D., Roel Nusse, Ph.D. and Calvin Kuo, M.D., Ph.D. from Stanford University; Claudia Janda, Ph.D. from the Princess Maxima Center for Pediatric Oncology; and Hans Clevers, M.D, Ph.D. from the Hubrecht Institute and Princess Maxima Center. Each has conducted extensive research on Wnt signaling, with findings that together shape Surrozen’s technology and approach to therapeutic development. The … Type: | 1 | 0 | 1 | 69 |
 | Hervolution Therapeutics Therapeutics for the Disease of Aging Immune therapy platform targeting Dark Genome antigens that contribute to aging, cancer, diabetes, and neurodegenerative diseases Oncology, Aging, Dark Genome, ALS, Diabetes, and Longevity Type: | 2 | 0 | 1 | 20 |
 | Mosa Meat Pioneering a cleaner, kinder way of making beef. In 2013, our Chief Scientific Officer Professor Mark Post unveiled the world’s first cultured meat hamburger to a packed press conference in London. The burger was harvested directly from cow cells, rather than raising and slaughtering a whole animal. It was the result of years of research at Maastricht University, and cost €250,000 to make. The effort was funded by Sergey Brin, the co-founder of Google. Our motivation was to find a new method to make real meat to feed our fast-growing population in a sustainable, healthy and animal-friendly way. Following the … Type: | 9 | 5 | 5 | 130 |
 | CellProthera SAS Pionnier de la thérapie régénératrice cardiaque CellProthera, a biotechnological company, has developed a unique therapeutic technique which enables the structural and functional regeneration of severe post-infarctus cardiac lesions. After European and national (FR/GB) authorization was obtained , CellProthera has started its I/IIB clinical trial in Humans. Heart Regeneration Type: | 14 | 7 | 6 | 33 |
 | Wandercraft Ordinary life for Extraordinary people We're hiring ! https://wandercraft.welcomekit.co/ Wandercraft ‘s job is to make wheelchair users walk again. We make real the promises of robotics by providing an ordinary life to extraordinary people. We have developed the first autonomous exo. In our world premiere clinical trials, persons with paraplegia walked human-like, autonomously and without crutches. The Wanderteam walks on the edge of robotics. We cooperate with world class university labs and medical centers in Europe and the US. Atalante is not only an exoskeleton. Atalante allows patients to stand up, without crutches. Atalante allows patients to finally be able … Tags: FrenchTech2030 Type: | 42 | 21 | 22 | 124 |
 | Bcell Design Best-in-class monoclonal antibodies with Human Fc Based in Illkirch-Graffenstaden (France), Bcell Design is a monoclonal design expert. The company has developed unique technologies to produce human Fc monoclonal antibodies with excellent reactivity. 1/ IVD Our high-quality monoclonal antibodies are specifically designed for in vitro diagnostics. They are used for positive controls, calibrators and quality controls. Some products have been tested and found reactive in DiaSorin LIAISON XL assays, BioMérieux Vidas, bioVendor KleeYa system etc... Our products are included in manual and automatic kits, under IVDR and FDA regulations. They are used as a quality control tool for all types of … Type: | 3 | 2 | 3 | 8 |
 | ENYO Pharma Developing therapeutics for diseases with impaired kidney function ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH). Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor. Type: | 8 | 3 | 5 | 32 |
Startup